ALSN(ALSN)
ALSN
Q4 2026 EPS Estimate
$2.42
Oct 29, 2026 · Reports after close
Revenue Estimate
$1.46B
FY2026E EPS$8.14
FY2027E EPS$10.95
Analyst Sentiment
Wall St. Consensus
Hold28 analysts·High coverage
52
Score
7 Buy (25%)15 Hold (54%)6 Sell (21%)
Rating Breakdown
Strong Buy
14%
Buy
621%
Hold
1554%
Sell
621%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$126.00
+2.9%
Consensus
$126.00
+2.9%
Bull
$126.00
+2.9%
12-Month Target Range28 analysts
$126.00$126.00$126.00
Current $122.40Consensus
Current Price
$122.40
Upside to Consensus
$3.60
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+4.74%
EPS+34.43%
FY2028
Rev+4.69%
EPS+17.05%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $5.93B | $6.21B | $6.51B |
| Low | $5.89B | $6.10B | $6.27B |
| High | $5.96B | $6.34B | $6.70B |
| EBITDA Avg | $1.14B | $1.45B | $1.64B |
| Low | $1.09B | $1.38B | $1.60B |
| High | $1.19B | $1.58B | $1.80B |
| EBIT Avg | $976M | $1.25B | $1.41B |
| Low | $923M | $1.17B | $1.37B |
| High | $1.03B | $1.38B | $1.57B |
| Net Income Avg | $702M | $918M | $1.05B |
| Low | $660M | $861M | $1.02B |
| High | $745M | $1.02B | $1.18B |
| EPS Avg | $8.14 | $10.95 | $12.81 |
| Low | $7.76 | $10.13 | $11.98 |
| High | $8.76 | $12.03 | $13.84 |
| Analysts (Rev / EPS) | 7 / 6 | 8 / 7 | 6 / 4 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.46B | $1.49B | $1.52B | $1.65B | $1.53B | $1.56B | $1.57B | $1.67B |
| Low | $1.43B | $1.47B | $1.47B | $1.60B | $1.48B | $1.51B | $1.52B | $1.62B |
| High | $1.49B | $1.51B | $1.56B | $1.69B | $1.57B | $1.60B | $1.61B | $1.71B |
| EBITDA Avg | $373M | $386M | $404M | $445M | $418M | $437M | $455M | $481M |
| Low | $350M | $354M | $394M | $433M | $407M | $425M | $443M | $467M |
| High | $404M | $425M | $413M | $455M | $427M | $446M | $465M | $492M |
| EBIT Avg | $288M | $302M | $320M | $360M | $333M | $352M | $370M | $395M |
| Low | $265M | $270M | $309M | $348M | $322M | $340M | $357M | $382M |
| High | $319M | $340M | $328M | $370M | $342M | $361M | $380M | $406M |
| Net Income Avg | $193M | $204M | $218M | $251M | $229M | $244M | $259M | $279M |
| Low | $175M | $178M | $210M | $241M | $220M | $235M | $249M | $268M |
| High | $218M | $235M | $225M | $259M | $237M | $252M | $267M | $288M |
| EPS Avg | $2.30 | $2.43 | $2.60 | $2.98 | $2.73 | $2.90 | $3.08 | $3.32 |
| Low | $2.08 | $2.12 | $2.50 | $2.87 | $2.62 | $2.79 | $2.96 | $3.19 |
| High | $2.59 | $2.80 | $2.68 | $3.08 | $2.82 | $3.00 | $3.18 | $3.42 |
| Analysts (Rev / EPS) | 5 / 5 | 5 / 5 | 4 / 3 | 4 / 3 | 4 / 3 | 4 / 3 | 3 / 4 | 3 / 4 |
